Here you go. MD's AGM presentation (Slide 11, 4 Nov'20) - as per the scale-up plan, capacity should be upto 5.4m devices per Qtr.
What's been a bit unclear is whether above represents all production capacity (HIV, OEM supply, all pipeline items - which use different devices and future versions pending release) or just OEM related supply.
My opinion is that the graph represents total supply, based around blister pack production levels (Galileo, Pascal, new Elion)
In any case, regardless of device type, immediate supply ability shouldn't be an issue considering there has to be several million devices stockpiled since Jan'21 production levels (some of which would be now going to Unitaid HIV order + OEM agreements like AccBio Ab + potential supply for NG Biotech Ab test + other partners/markets being developed)
- Forums
- ASX - By Stock
- AT1
- Media Update
Media Update, page-613
-
-
- There are more pages in this discussion • 1,233 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.001(4.00%) |
Mkt cap ! $16.61M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.5¢ | $2.798K | 111.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 169773 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 37954 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 169773 | 0.025 |
4 | 857050 | 0.024 |
4 | 1100391 | 0.023 |
6 | 467973 | 0.022 |
3 | 194292 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 37954 | 1 |
0.027 | 26459 | 2 |
0.028 | 196971 | 3 |
0.029 | 425248 | 5 |
0.030 | 434288 | 7 |
Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |